Journal of Transplantation / 2012 / Article / Fig 2

Review Article

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation

Figure 2

Proposed management algorithm for AMR in heart transplantation. AMR: antibody-mediated rejection, CNI: calcineurin inhibitors, DSA: donor specific antibodies, IF: immunofluorescence, IH: immunohistochemistry, IVIG: intravenous immunoglobulin, MMF: mycophenolate mofetil, pAMR: ISHLT pathologic AMR grade 0–3, and PSI: proliferation signal inhibitor. *Endomyocardial biopsy frequency as per institution protocol. DSA monitoring at week 2, months 1, 3, 6, and 12 in first year after transplant and annually thereafter. Assessment of allograft function every month and DSA every 3 months until two negative or unchanged results.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.